Report Detail

Pharma & Healthcare Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019

  • RnM3160787
  • |
  • 22 March, 2019
  • |
  • Global
  • |
  • 54 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019, provides an overview of the Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline landscape.

Shigella Infections (Shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramps and fever. Predisposing factors include eating contaminated food, age, international travelers and homosexual men. Treatment includes antibiotics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacillary Dysentery (Shigellosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 6 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 3, 2 and 2 molecules, respectively.

Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Bacillary Dysentery (Shigellosis) (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Bacillary Dysentery (Shigellosis) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Bacillary Dysentery (Shigellosis) (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Bacillary Dysentery (Shigellosis) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Bacillary Dysentery (Shigellosis) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Bacillary Dysentery (Shigellosis) (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Bacillary Dysentery (Shigellosis) - Overview

              Bacillary Dysentery (Shigellosis) - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Bacillary Dysentery (Shigellosis) - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Bacillary Dysentery (Shigellosis) - Companies Involved in Therapeutics Development

                                      Akthelia Pharmaceuticals Ltd

                                        Chongqing Zhifei Biological Products Co Ltd

                                          GlaxoSmithKline Plc

                                            Immuron Ltd

                                              Polyneuron Pharmaceuticals AG

                                                Protein Potential LLC

                                                  Bacillary Dysentery (Shigellosis) - Drug Profiles

                                                    (shigella + typhoid) (Bivalent) vaccine - Drug Profile

                                                      Product Description

                                                        Mechanism Of Action

                                                          R&D Progress

                                                            AKT-10081 - Drug Profile

                                                              Product Description

                                                                Mechanism Of Action

                                                                  R&D Progress

                                                                    GSK-3536852A - Drug Profile

                                                                      Product Description

                                                                        Mechanism Of Action

                                                                          R&D Progress

                                                                            GVXNSD-133 - Drug Profile

                                                                              Product Description

                                                                                Mechanism Of Action

                                                                                  R&D Progress

                                                                                    IMM-124E - Drug Profile

                                                                                      Product Description

                                                                                        Mechanism Of Action

                                                                                          R&D Progress

                                                                                            infectious disease vaccine - Drug Profile

                                                                                              Product Description

                                                                                                Mechanism Of Action

                                                                                                  R&D Progress

                                                                                                    PN-109 - Drug Profile

                                                                                                      Product Description

                                                                                                        Mechanism Of Action

                                                                                                          R&D Progress

                                                                                                            SC-599 - Drug Profile

                                                                                                              Product Description

                                                                                                                Mechanism Of Action

                                                                                                                  R&D Progress

                                                                                                                    SF2a-TT15 - Drug Profile

                                                                                                                      Product Description

                                                                                                                        Mechanism Of Action

                                                                                                                          R&D Progress

                                                                                                                            shigella (bivalent) vaccine - Drug Profile

                                                                                                                              Product Description

                                                                                                                                Mechanism Of Action

                                                                                                                                  R&D Progress

                                                                                                                                    shigella [serotype 2a] vaccine - Drug Profile

                                                                                                                                      Product Description

                                                                                                                                        Mechanism Of Action

                                                                                                                                          R&D Progress

                                                                                                                                            shigella [strain 53G] vaccine - Drug Profile

                                                                                                                                              Product Description

                                                                                                                                                Mechanism Of Action

                                                                                                                                                  R&D Progress

                                                                                                                                                    shigella vaccine - Drug Profile

                                                                                                                                                      Product Description

                                                                                                                                                        Mechanism Of Action

                                                                                                                                                          R&D Progress

                                                                                                                                                            shigella vaccine - Drug Profile

                                                                                                                                                              Product Description

                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                  R&D Progress

                                                                                                                                                                    shigella vaccine - Drug Profile

                                                                                                                                                                      Product Description

                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                          R&D Progress

                                                                                                                                                                            shigella vaccine - Drug Profile

                                                                                                                                                                              Product Description

                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                    Shigetec - Drug Profile

                                                                                                                                                                                      Product Description

                                                                                                                                                                                        Mechanism Of Action

                                                                                                                                                                                          R&D Progress

                                                                                                                                                                                            Small Molecule to Activate IL-10 for Bacterial Infections and Crohn's Disease - Drug Profile

                                                                                                                                                                                              Product Description

                                                                                                                                                                                                Mechanism Of Action

                                                                                                                                                                                                  R&D Progress

                                                                                                                                                                                                    Bacillary Dysentery (Shigellosis) - Dormant Projects

                                                                                                                                                                                                      Bacillary Dysentery (Shigellosis) - Product Development Milestones

                                                                                                                                                                                                        Featured News & Press Releases

                                                                                                                                                                                                          Jul 29, 2013: GlycoVaxyn Secures CHF 5.1 Million Strategic Translation Award From the Wellcome Trust to Finance Clinical Development of Shigella Vaccine

                                                                                                                                                                                                            Jan 27, 2012: IVI Granted Two U.S. Patents On Dysentery Vaccine Inventions

                                                                                                                                                                                                              Oct 08, 2010: GlycoVaxyn Phase I Clinical Study Shows Positive Data With Shigella Dysenteriae Vaccine Candidate Against Severe Diarrheal Disease

                                                                                                                                                                                                                Feb 23, 2010: GlycoVaxyn Initiates Phase I Clinical Study with Bioconjugate Vaccine

                                                                                                                                                                                                                  Feb 15, 2007: IVI Scientists Develop New Laboratory Animal Model For Shigella

                                                                                                                                                                                                                    Appendix

                                                                                                                                                                                                                      Methodology

                                                                                                                                                                                                                        Coverage

                                                                                                                                                                                                                          Secondary Research

                                                                                                                                                                                                                            Primary Research

                                                                                                                                                                                                                              Expert Panel Validation

                                                                                                                                                                                                                                Contact Us

                                                                                                                                                                                                                                  Disclaimer

                                                                                                                                                                                                                                  Summary:
                                                                                                                                                                                                                                  Get latest Market Research Reports on Bacillary Dysentery (Shigellosis). Industry analysis & Market Report on Bacillary Dysentery (Shigellosis) is a syndicated market report, published as Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019. It is complete Research Study and Industry Analysis of Bacillary Dysentery (Shigellosis) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                                                                                                                  Last updated on

                                                                                                                                                                                                                                  REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                                                                                  Purchase this Report

                                                                                                                                                                                                                                  $2,000.00
                                                                                                                                                                                                                                  $4,000.00
                                                                                                                                                                                                                                  $6,000.00
                                                                                                                                                                                                                                  1,542.00
                                                                                                                                                                                                                                  3,084.00
                                                                                                                                                                                                                                  4,626.00
                                                                                                                                                                                                                                  1,844.00
                                                                                                                                                                                                                                  3,688.00
                                                                                                                                                                                                                                  5,532.00
                                                                                                                                                                                                                                  306,460.00
                                                                                                                                                                                                                                  612,920.00
                                                                                                                                                                                                                                  919,380.00
                                                                                                                                                                                                                                  168,220.00
                                                                                                                                                                                                                                  336,440.00
                                                                                                                                                                                                                                  504,660.00
                                                                                                                                                                                                                                  Credit card Logo

                                                                                                                                                                                                                                  Related Reports


                                                                                                                                                                                                                                  Reason to Buy

                                                                                                                                                                                                                                  Request for Sample of this report